Ceretrieve has designed and developed CathTrap, a neurothrombectomy system with integrated embolic protection for ischemic stroke endovascular treatment. CathTrap provides physicians with a safe, easy-to-use device to prevent distal embolization during thrombectomy procedures for better treatment efficiency and improved clinical outcomes for patients.

Ceretrieves aspiration catheter has an expandable soft tip that can enlarge its diameter from 6F to the clot size in order to provide a powerful aspiration force to extract and ingest the clot without compromising trackability in reaching the clot.

Ceretrieve is a portfolio company of Trendlines.